血小板激活和血栓炎症的增加在早期和晚期发病的孕前症中
Kunal Singh1,2, Massimiliano Lia2,3, Akshay Prakasan Sheeja1
1Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, University Hospital Leipzig, Leipzig University, Germany.
Research and practice in thrombosis and haemostasis
|August 1, 2025
概括
血栓炎症的机制在早期和晚期发病的孕前之间有所不同. 孕产妇的血小板激活是晚期发作的孕前的关键,这表明疾病进展的不同途径.
科学领域:
- 产科和妇科 产科和妇科
- 血管生物学 血管生物学
- 免疫学 免疫学 免疫学
背景情况:
- 孕前是一种妊娠并发症,其特征是高血压和升高的sFlt-1/PlGF.
- 它呈现为早期发病 (E-PE) 或晚发病 (L-PE) 的孕前症.
- 血栓炎症,包括血小板激活和无菌炎症,与孕前的病理生理学有关,但E-PE与L-PE的差异调节尚不清楚.
研究的目的:
- 研究E-PE与L-PE中母亲血小板激活,炎症和内皮功能障碍的不同作用.
主要方法:
- 流细胞计分析了全血中的血小板激活标记物 (P-选择素,活性αIIbβ3).
- 测量了白血素-1β (IL-1β) 和可溶性血管细胞粘附分子-1 (sVCAM-1) 的血水平.
主要成果:
- 与对照组相比,E-PE和L-PE都显示出血小板活化增加和血IL-1β和sVCAM-1的升高.
- 母胎血小板激活与疾病严重程度和炎症标志物相关,特别是在L-PE.
- 在αIIbβ3表达和sFlt-1,IL-1β或sVCAM-1之间没有发现显著的相关性.
结论:
- 血栓炎症在L-PE和E-PE中受到不同的调节.
- 母亲因素,如血小板激活,似乎在L-PE病理生理学中发挥着重要作用.
- 需要对更大的队列进行进一步的研究,以充分理解这些机制差异.
相关概念视频
Formation of the Platelet Plug
7.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
646
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
646
Anticoagulant Drugs: Low-Molecular-Weight Heparins
911
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
911
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Peripheral Artery Disease I: Introduction
33
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
33


